Press releases, news coverage, industry events, and multimedia resources from Laborate Pharmaceuticals India Ltd.
Featured Story
"Access to quality medicines is not a privilege — it is a responsibility we carry with every shipment we dispatch." — Managing Director, Laborate Pharmaceuticals
Laborate Pharmaceuticals India Ltd. has achieved a significant milestone, expanding its WHO-prequalified medicine portfolio to reach healthcare systems across 35 countries. This expansion follows a series of facility upgrades across our five GMP-certified manufacturing plants in Haryana and Himachal Pradesh, enabling increased production capacity for essential medicines across antimalarial, anti-infective, and cardiovascular therapeutic categories.
The achievement marks a continued commitment to quality-first pharmaceutical manufacturing — ensuring that rigorous global standards are met not as a compliance exercise, but as a reflection of the company's core values.
Read Full StoryThe latest official communications from Laborate Pharmaceuticals — regulatory approvals, strategic partnerships, facility milestones, and industry recognition.
Three formulations from our Paonta Sahib facility have received WHO Prequalification status, enabling procurement by UN agencies and access to critical global health markets.
Read AnnouncementOur Panipat Unit IV manufacturing facility has been awarded ISO 14001:2015 certification, affirming our commitment to sustainable pharmaceutical operations and environmental stewardship.
Read AnnouncementA multi-year contract manufacturing agreement has been formalised with a European partner, leveraging Laborate's regulatory-compliant facilities to supply the EU and MENA markets.
Read AnnouncementHow the pharmaceutical industry and international press are reporting on Laborate's manufacturing excellence, export growth, and quality achievements.
Read Article
Read Article
Read Article
Meet Laborate at global pharmaceutical exhibitions, regulatory conferences, and industry summits — where science, policy, and partnership converge.
API India 2026 — Active Pharmaceutical Ingredients Exhibition
CPhI Worldwide 2026 — Leading Pharmaceutical Ingredients Show
Pharmexil Export Excellence Awards 2026
ACHEMA 2027 — World Forum for the Chemical and Process Industries
Laborate's story extends across five continents. Our medicines, our milestones, and our manufacturing excellence are covered by international industry press and recognised by global regulators.
Authorised assets for journalists, partners, and media professionals. All materials are approved for editorial use with proper attribution to Laborate Pharmaceuticals India Ltd.
An overview of Laborate Pharmaceuticals — history, capabilities, facilities, export reach, and key leadership.
PDF — 3.2 MB DownloadOfficial logos, colour palette, typography, and usage guidelines for editorial and media use.
PDF — 8.6 MB DownloadThe complete Laborate formulations catalogue — 1,500+ products across all therapeutic categories and dosage forms.
PDF — 12.4 MB DownloadFinancial performance, operational highlights, sustainability commitments, and strategic outlook for the year ended March 2025.
PDF — 5.8 MB DownloadFor press releases, interview requests, broadcast enquiries, and media partnerships — our team is available to assist journalists and media professionals.
[Communications Director]
Head of Corporate Communications
Global & India Media
communications@laborate.com[Media Relations Manager]
Media Relations & Press Office
Domestic Press & Trade Media
media@laborate.com[International Press Officer]
International Press & Broadcast
Europe, Africa & Asia-Pacific
international.media@laborate.comFor interviews, exclusive features, broadcast access, or partnership enquiries — our team responds within one business day.
